Patient characteristics according to treatment arm
Characteristic . | Chemo, n = 83 . | HDT/SCT, n = 81 . | P . |
|---|---|---|---|
| Median age, y | 56 | 57 | NS |
| Sex, M/F | 43/40 | 52/29 | NS |
| Hemoglobin level, less than 100 g/L, % | 47 | 30 | .03 |
| Calcium level, greater than or equal to 2.87, % | 10 | 15 | NS |
| Creatinine level, greater than or equal to 176.8 μM, % | 10 | 15 | NS |
| Serum albumin level, less than 35 g/L, % | 31 | 34 | NS |
| LDH, greater than 350 IU/L, % | 12 | 10 | NS |
| Lytic bone lesions, % | 67 | 70 | NS |
| β2-microglobulin, greater than 339 nM, % | 37 | 30 | NS |
| Phase-S, greater than 2, % | 40 | 37 | NS |
| M-protein type, no. | |||
| IgG | 65 | 47 | .02 |
| IgA | 11 | 30 | .003 |
| Light chain | 23 | 21 | NS |
| Others | 1 | 2 | NS |
Characteristic . | Chemo, n = 83 . | HDT/SCT, n = 81 . | P . |
|---|---|---|---|
| Median age, y | 56 | 57 | NS |
| Sex, M/F | 43/40 | 52/29 | NS |
| Hemoglobin level, less than 100 g/L, % | 47 | 30 | .03 |
| Calcium level, greater than or equal to 2.87, % | 10 | 15 | NS |
| Creatinine level, greater than or equal to 176.8 μM, % | 10 | 15 | NS |
| Serum albumin level, less than 35 g/L, % | 31 | 34 | NS |
| LDH, greater than 350 IU/L, % | 12 | 10 | NS |
| Lytic bone lesions, % | 67 | 70 | NS |
| β2-microglobulin, greater than 339 nM, % | 37 | 30 | NS |
| Phase-S, greater than 2, % | 40 | 37 | NS |
| M-protein type, no. | |||
| IgG | 65 | 47 | .02 |
| IgA | 11 | 30 | .003 |
| Light chain | 23 | 21 | NS |
| Others | 1 | 2 | NS |
LDH indicates lactate dehydrogenase; NS, not significant.